Pharmacy Practice and Administration

The scope of the Special Issue is research and reviews on evaluations of current practice, innovations in medication management, developments in therapeutics, and pharmaceutical science research that informs and improves practice and administration, as well as the social and administrative pharmacy....

Full description

Bibliographic Details
Format: eBook
Language:English
Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
Subjects:
MUR
Online Access:Open Access: DOAB: description of the publication
Open Access: DOAB, download the publication
LEADER 05608namaa2201717uu 4500
001 doab91187
003 oapen
005 20220812
006 m o d
007 cr|mn|---annan
008 220812s2022 xx |||||o ||| 0|eng d
020 |a 9783036547299 
020 |a 9783036547305 
020 |a books978-3-0365-4729-9 
024 7 |a 10.3390/books978-3-0365-4729-9  |2 doi 
040 |a oapen  |c oapen 
041 0 |a eng 
042 |a dc 
072 7 |a KND  |2 bicssc 
072 7 |a M  |2 bicssc 
720 1 |a Adunlin, Georges  |4 edt 
720 1 |a Adunlin, Georges  |4 oth 
245 0 0 |a Pharmacy Practice and Administration 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2022 
300 |a 1 online resource (260 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |f Unrestricted online access  |2 star 
520 |a The scope of the Special Issue is research and reviews on evaluations of current practice, innovations in medication management, developments in therapeutics, and pharmaceutical science research that informs and improves practice and administration, as well as the social and administrative pharmacy. We will mainly feature original research, reviews, short reports, and clinical studies, but also case reports, descriptive/how-to, and commentary submissions for consideration. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |u https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Manufacturing industries  |2 bicssc 
650 7 |a Medicine and Nursing  |2 bicssc 
653 |a ability 
653 |a abuse 
653 |a acute care 
653 |a additional monitoring 
653 |a adolescents and young adults 
653 |a adverse drug events 
653 |a adverse event reporting 
653 |a ambulatory care facilities 
653 |a antimicrobial resistance (AMR) 
653 |a asynchronous learning 
653 |a attitudes 
653 |a availability 
653 |a awareness 
653 |a barriers 
653 |a biosensing technology 
653 |a black triangle 
653 |a business 
653 |a cancer patients 
653 |a Chief Pharmaceutical Officer's Global Health Fellowship 
653 |a Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) 
653 |a community pharmacies 
653 |a community pharmacists 
653 |a community pharmacy 
653 |a community pharmacy services 
653 |a contraception 
653 |a COVID-19 
653 |a CPhOGH Fellows 
653 |a CwPAMS 
653 |a decision to study in pharmacy 
653 |a defined daily dose 
653 |a digital medicine system 
653 |a drug disposal 
653 |a drug-related problems 
653 |a e-prescription 
653 |a emergency contraception 
653 |a emergency contraceptives 
653 |a emergency prescribing 
653 |a entrepreneurship 
653 |a environment 
653 |a fellowship 
653 |a financial management 
653 |a fragility 
653 |a Germany 
653 |a global health 
653 |a health partnerships 
653 |a health workforce 
653 |a high fidelity 
653 |a information gathering 
653 |a internal medicine ward 
653 |a interprofessional 
653 |a intervention 
653 |a Jazan 
653 |a leadership 
653 |a learning activity 
653 |a levonorgestrel 
653 |a Medicaid 
653 |a Medicare 
653 |a medication adherence 
653 |a medication event monitoring system 
653 |a medication review 
653 |a medication safety 
653 |a medication-related problems 
653 |a medicine consumption 
653 |a mortality 
653 |a MUR 
653 |a mystery calls 
653 |a National Health Service (NHS) 
653 |a non-prescription medicines 
653 |a nonadherence 
653 |a nursing 
653 |a older adults 
653 |a outcomes 
653 |a pain 
653 |a patient education 
653 |a perception 
653 |a pharmacist 
653 |a pharmacists 
653 |a pharmacogenomics 
653 |a pharmacovigilance 
653 |a pharmacy 
653 |a pharmacy education 
653 |a pharmacy law and regulation 
653 |a pharmacy management 
653 |a pharmacy practice 
653 |a pharmacy students 
653 |a polypharmacy 
653 |a practice 
653 |a pregabalin 
653 |a prescription errors 
653 |a prescription opioids 
653 |a prescription writing 
653 |a prescriptions 
653 |a pricing 
653 |a Program of All-Inclusive Care for the Elderly 
653 |a reproductive health 
653 |a Saudi Arabia 
653 |a selecting pharmacy as a first choice 
653 |a simulation 
653 |a SPICE-R2 
653 |a standardized mortality ratio 
653 |a standardized patients 
653 |a student survey 
653 |a students 
653 |a systematic review 
653 |a Taiwan 
653 |a ulipristal acetate 
653 |a underlying cause of death 
653 |a unused medication 
653 |a virtual learning 
793 0 |a DOAB Library. 
856 4 0 |u https://directory.doabooks.org/handle/20.500.12854/91187  |7 0  |z Open Access: DOAB: description of the publication 
856 4 0 |u https://mdpi.com/books/pdfview/book/5833  |7 0  |z Open Access: DOAB, download the publication